Literature DB >> 1314581

Venous smooth muscle contains vasoconstrictor ETB-like receptors.

S Moreland1, D M McMullen, C L Delaney, V G Lee, J T Hunt.   

Abstract

Two endothelin (ET) receptor subtypes have been identified to date: the ETA receptor which preferentially binds ET-1 over ET-3, and the ETB receptor which is non-selective. This study characterized the ET receptor subtypes present in several vascular smooth muscle preparations using standard in vitro techniques. In all but one of the arteries tested, ET-3 was significantly less potent than ET-1. In contrast, the potency of ET-3 was very similar to that of ET-1 in all of the veins. The selective ETA receptor antagonist BQ-123 blunted the ET-1 contractions in rabbit carotid artery, but not in saphenous vein. The selective ETB receptor ligand sarafotoxin S6c contracted the rabbit saphenous vein, but not the carotid artery. These data suggest that vascular smooth muscle cells express ETA and ETB receptors. Stimulation of either receptor subtype can result in force development.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1314581     DOI: 10.1016/0006-291x(92)91163-k

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  41 in total

Review 1.  Role of endothelin in diabetic vascular complications.

Authors:  H C Lam
Journal:  Endocrine       Date:  2001-04       Impact factor: 3.633

Review 2.  Endothelins. Vascular actions and clinical implications.

Authors:  T Sakurai; K Goto
Journal:  Drugs       Date:  1993-11       Impact factor: 9.546

3.  Protective effect of Melothria maderaspatana leaf fraction on electrolytes, catecholamines, endothelial nitric oxide synthase and endothelin-1 peptide in uninephrectomized deoxycorticosterone acetate-salt hypertensive rats.

Authors:  Chinnadurai Veeramani; Khalid S Al-Numair; Govindasamy Chandramohan; Mohammed A Alsaif; Kodukkur Viswanathan Pugalendi
Journal:  J Nat Med       Date:  2012-01-14       Impact factor: 2.343

Review 4.  Air Pollution-Induced Vascular Dysfunction: Potential Role of Endothelin-1 (ET-1) System.

Authors:  Jordan Finch; Daniel J Conklin
Journal:  Cardiovasc Toxicol       Date:  2016-07       Impact factor: 3.231

5.  The effects of the endothelin ETA receptor antagonist, FR 139317, on infarct size in a rabbit model of acute myocardial ischaemia and reperfusion.

Authors:  L McMurdo; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

6.  Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ-123 and PD 145065.

Authors:  T D Warner; G H Allcock; J R Vane
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

7.  Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary circulation.

Authors:  D D Ivy; J P Kinsella; S H Abman
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

8.  Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788.

Authors:  K Ishikawa; M Ihara; K Noguchi; T Mase; N Mino; T Saeki; T Fukuroda; T Fukami; S Ozaki; T Nagase
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

9.  Endothelin receptors mediating contraction in goat cerebral arteries.

Authors:  J B Salom; G Torregrosa; M D Barberá; T Jover; E Alborch
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

10.  Effects of the ETA/ETB receptor antagonist, bosentan on endothelin-1-induced myocardial ischaemia and oedema in the rat.

Authors:  J G Filep; A Fournier; E Földes-Filep
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.